companies / sciencecorp-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-07 json
| total_raised | 230,000,000230.0M | ○ |
|---|---|---|
| founded | 2021 | |
| hq | USA | |
| industry | unknown | |
| stage | series-b+ |
Science Corporation develops neural-interface devices led by PRIMA, a retinal implant restoring functional vision in macular-degeneration patients, plus biohybrid interfaces. It treats AMD, retinitis pigmentosa, and Stargardt patients while serving neural-engineering labs. PRIMA results were published in NEJM.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-03-01 | series-d+ | 230,000,000230.0M | null | ○ |
| investor | src |
|---|---|
| Khosla Ventures | ○ |
| Lightspeed Venture Partners | ○ |
| fact | status | src |
|---|---|---|
| Series D+, $230.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-27latest_round: series-d+, $230.0M, 2026-03-01, lead: khosla → series-d+, $230.0M, 2026-03-01, lead: null, ○ 2026-05-07 | latest_round | series-d+, $230.0M, 2026-03-01, lead: khosla → series-d+, $230.0M, 2026-03-01, lead: null | ○ 2026-05-07 |
Records begin 2026-09-24. all_changes